GoodRx (GDRX) Earnings Date, Estimates & Call Transcripts $4.80 +0.19 (+4.12%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GoodRx Earnings Summary Upcoming Q3 Earnings DateMay. 7Before Market OpensEstimatedConsensus EPS (Aug. 8) $0.09 Actual EPS (Aug. 8) $0.08 Missed By -$0.01 Actual Revenue (Aug. 8) $200.60MGoodRx released Q2 2024 earnings on August 8, 2024, reporting an EPS of $0.08, which missed the consensus estimate of $0.09 by $0.01. Quarterly revenue rose 5.7% year-over-year to $200.60 million, above the consensus estimate of $200.47 million. With a trailing EPS of $0.05, GoodRx's earnings are expected to grow 38.46% next year, from $0.13 to $0.18 per share. Q2 2024 Earnings ResourcesQ2 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)SEC FilingGDRX Upcoming EarningsGoodRx's Q1 2025 earnings is scheduled for Wednesday, May 7, 2025, with a conference call scheduled on Thursday, May 8, 2025 at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get GoodRx Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GoodRx and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGDRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GDRX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. GoodRx Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20251$0.05$0.05$0.05 Q2 20251$0.06$0.06$0.06 Q3 20251$0.06$0.06$0.06 Q4 20251$0.06$0.06$0.06 FY 20254$0.23$0.23 $0.23 GoodRx Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/7/2025(Estimated)--------8/8/2024Q2 2024$0.09$0.08 -$0.01$0.02$200.47M$200.60M5/9/2024Q1 2024$0.04$0.03 -$0.01$0.06$196.20M$197.88M2/29/2024Q4 2023$0.02$0.02-$0.10$195.59M$196.64M11/9/2023Q3 2023$0.06$0.06-$0.09$188.52M$180.00M8/9/2023Q2 2023$0.01$0.02+$0.01-$0.10$186.90M$189.68M5/10/2023Q1 2023$0.01$0.01-$0.03$181.87M$183.99M GoodRx Earnings - Frequently Asked Questions When is GoodRx's earnings date? GoodRx has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based off last year's report dates. Learn more on GDRX's earnings history. What guidance has GoodRx issued on next quarter's earnings? GoodRx issued an update on its first quarter 2025 earnings guidance on Thursday, February, 27th. The company issued revenue guidance of $201.0 million-$205.0 million, compared to the consensus revenue estimate of $202.6 million. Did GoodRx beat their earnings estimates last quarter? In the previous quarter, GoodRx (NASDAQ:GDRX) missed the analysts' consensus estimate of $0.09 by $0.01 with a reported earnings per share (EPS) of $0.08. Learn more on analysts' earnings estimate vs. GDRX's actual earnings. How can I listen to GoodRx's earnings conference call? The conference call for GoodRx's latest earnings report can be listened to online. Listen to Conference Call How can I read GoodRx's conference call transcript? The conference call transcript for GoodRx's latest earnings report can be read online. Read Transcript How can I view GoodRx's earnings report? GoodRx's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does GoodRx generate each year? GoodRx (NASDAQ:GDRX) has a recorded annual revenue of $792.32 million. How much profit does GoodRx generate each year? GoodRx (NASDAQ:GDRX) has a recorded net income of -$8.87 million. GDRX has generated $0.05 earnings per share over the last four quarters. What is GoodRx's price-to-earnings ratio? GoodRx (NASDAQ:GDRX) has a forward price-to-earnings ratio of 36.64. The price/earnings-to-growth ratio is 2.46. What is GoodRx's EPS forecast for next year? GoodRx's earnings are expected to grow from $0.13 per share to $0.18 per share in the next year, which is a 38.46% increase. More Earnings Resources from MarketBeat Related Companies QXO Earnings Results Etsy Earnings Results Globant Earnings Results Lyft Earnings Results Amentum Earnings Results MARA Earnings Results WillScot Mobile Mini Earnings Results Remitly Global Earnings Results StoneCo Earnings Results TriNet Group Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InWhy It May Be Time to Buy CrowdStrike Stock Heading Into EarningsCan IBM’s Q1 Earnings Spark a Breakout for the Stock? This page (NASDAQ:GDRX) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GDRX Stock Free GDRX Stock Alerts